Produktname:Methyl 3-Amino-2-Chloro-6-Fluorobenzoate

IUPAC Name:methyl 3-amino-2-chloro-6-fluorobenzoate

CAS:1268830-74-5
Molekulare Formel:C8H7ClFNO2
Reinheit:95%+
Katalognummer:CM448010
Molekulargewicht:203.6

Packungseinheit Verfügbarer Vorrat Preis($) Menge
CM448010-100mg 3-4 Weeks ǕȌDz
CM448010-250mg 3-4 Weeks ȦDzƤ
CM448010-1g 4-5 Weeks ȌɐȦ
CM448010-5g 5-6 Weeks ǕɐƱȷ

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

   refresh    

Produkt-Details

CAS-Nr.:1268830-74-5
Molekulare Formel:C8H7ClFNO2
Schmelzpunkt:-
SMILES-Code:COC(=O)C1=C(Cl)C(N)=CC=C1F
Dichte:
Katalognummer:CM448010
Molekulargewicht:203.6
Siedepunkt:
Mdl-Nr.:MFCD24646162
Lagerung:

Column Infos

Tinlorafenib
The Journal of Medicinal Chemistry releases an article titled "Identification of the Clinical Candidate PF-07284890 (ARRY-461), a Highly Potent and Brain Penetrant BRAF Inhibitor for the Treatment of Cancer". Mutations in the BRAF gene result in MAPK pathway activation that are most commonly found in human melanomas. The BRAF V600E mutation is among the most frequent types. Present BRAF inhibitors have significantly improved treatment outcomes for patients with BRAF V600-mutant cancers. However, their effectiveness is limited by disease progression in the brain as they don’t adequately penetrate the blood-brain barrier (BBB).
Pfizer’s Tinlorafenib (formerly PF 07284890) is a highly brain-penetrant inhibitor of BRAF V600-mutant tumors, and currently in a phase 1 clinical trial (NCT04543188). 

Related Products